Fast forward to Jan23 and this is what I think the market will have on its mind re MSB
- cap raise just completed late 2022, none expected in the near horizon
- Ryoncil BLA under review (assuming not rejected by FDA this month), with outcome known any any time between Jan23 - Mar23.
- CHF FDA meeting held, minutes / clarity on approval pathway to be announced at any time between Jan23-Mar23.
- CLBP phase 3 trial commenced with ongoing recruitment updates and market weighing up chance of potential an early stop end of 2023 (depending on recruitment pace & patient outcomes on interim analysis)
Obviously these can go either way, but at current valuations... it doesn't appear any upside, on some very near term outcomes, has been priced in at all. Downside is known... it can go to $0.00.
Time is coming, page-219
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |